Article

Patterns of Glucose Metabolism in [<sup>18</sup>F]FDG PET Indicate Regional Variability and Neurodegeneration in the Progression of Alzheimer’s Dementia

2023-11-11

Abstract excerpt

In disorders of cognitive impairment, such as Alzheimer’s disease, neurodegeneration is the final common pathway of disease progression. Modulating, reversing, or preventing disease progression is a clinical imperative most likely to succeed following accurate and explanatory understanding of neurodegeneration, requiring enhanced consistency with quantitative measurements and expanded interpretability of complex d...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 36177a60-6279-5a15-b05d-5897f8264d2a
DOI: 10.1101/2023.11.10.23298396

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Patterns of Glucose Metabolism in [<sup>18</sup>F]FDG PET Indicate Regional Variability and Neurodegeneration in the Progression of Alzheimer’s DementiaDOI 10.1101/2023.11.10.23298396Read

Meta analysis of glucose metabolism across Alzheimer’s, Parkinson’s and ALS Reveals emergence of adaptive brain glucometabolic responses and associated neurological functional profilesSemantic proximity Read

Multimodal axes reveal individualized amyloid-β, tau, and neurodegeneration coupling in aging and Alzheimer’s diseaseSemantic proximity Read

Identification and Validation of New Molecular Subtypes within the Early and Late Mild Cognitive Impairment Stages of Alzheimer’s DiseaseSemantic proximity Read

Spatially Distributed Amyloid-β Reduces Glucose Metabolism in Mild Cognitive Impairment.Semantic proximity Read

Neuro-Metabolic and Vascular Dysfunction as an Early Diagnostic for Alzheimer’s Disease and Related DementiasSemantic proximity Read

Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease.Semantic proximity Read

Elucidating the neuropathological and molecular heterogeneity of amyloid-beta and tau in Alzheimer's disease through machine learning and transcriptomic integrationSemantic proximity Read

Multiscale Metabolic Covariance Networks Uncover Stage-Specific Biomarker Signatures Across the Alzheimer’s Disease ContinuumSemantic proximity Read

A unified model for staging amyloid and tau pathology in Alzheimer’s diseaseSemantic proximity Read

Multiscale networks in Alzheimer’s disease identify brain hypometabolism as central across biological scalesSemantic proximity Read

Multi-Omics Modelling of Plasma pTau181, GFAP, and Metabolic Features Enables Risk Stratification in Prodromal Alzheimer’s DiseaseSemantic proximity Read